Johnson & Johnson (J&J) has been mandated to pay $2.5 million to an autistic man who developed male breasts, a condition known as gynecomastia, as a result of taking the antipsychotic drug Risperdal.
A Philadelphia jury ordered J&J to pay the sum for failing to warn consumers that Risperdal could cause gynecomastia. According to the mans family, the autistic boy took the drug in 2002 and later developed 46 DD breasts.
This was the first lawsuit of its kind after approximately 1,000 cases were settled in recent years. J&J is still facing more than 3,000 cases over the gynecomastia side effect.
The family's lawyers contend that J&J officials illegally encouraged doctors to prescribe the medication to children prior to the Food & Drug Administrations approval for sales. They also argued that J&J officials intentionally hid study results showing that Risperdal caused abnormal breast development in boys.
In 2006, the drug was approved for treating behavior in autistic children, but the label was later updated to indicate that gynecomastia had been seen in about 2.3 percent of pediatric patients.
The Food and Drug Administrations commissioner, David Kessler, actually served as a paid witness for the family and testified that J&J knew about the risks associated with Risperdal.
About 10 to 25 percent of all gynecomastia cases are caused by prescribed medications, some common signs of enlarged breast growth among males include:
- Pain in the breast
- Nipple discharge
If you or someone you love has suffered serious side effects as a result of taking Risperdal, the victim may be entitled to compensation for medical expenses, lost wages and pain and suffering.
our attorneys are dedicated to fighting for the rights of the injured and can help you determine what your legal options are if you suffered serious side effects after taking Risperdal.